Oligoclonal expansion and loss of cytotoxic functionality of CAR-T cells in a DLBCL patient after CD19.CAR-T cell therapy

被引：0

作者：

Mueller, F. ^{[1
,2
]}

Schwingen, N. R. ^{[1
]}

Eisenhauer, N. ^{[1
]}

Aigner, M. ^{[1
,2
]}

Schletter, M. ^{[1
]}

Lutzny-Geier, G. ^{[1
]}

Lischer, C. ^{[3
]}

Guese, E. ^{[1
]}

Gebhard, C. ^{[4
]}

Rehli, M. ^{[4
,5
]}

Gonzalez, Vera J. ^{[3
]}

Eckstein, M. ^{[6
]}

Wiesmueller, M. ^{[7
]}

Erber, R. ^{[6
]}

Bruns, H. ^{[1
,2
]}

Mackensen, A. ^{[1
,2
]}

Voelkl, S. ^{[1
,2
]}

机构：

[1] Univ Hosp Erlangen, Dept Internal Med Hematol & Oncol 5, Erlangen, Germany

[2] Bavarian Ctr Canc Res BZKF, Partner Site Erlangen, Erlangen, Germany

[3] Univ Hosp Erlangen, Dept Dermatol, Erlangen, Germany

[4] Leibniz Inst Immunotherapy, Regensburg, Germany

[5] Univ Hosp Regensburg, Dept Internal Med 3, Regensburg, Germany

[6] Univ Hosp Erlangen, Inst Pathol, Comprehens Canc Ctr Erlangen EMN, Erlangen, Germany

[7] Univ Hosp Erlangen, Dept Radiol, Erlangen, Germany

来源：

ONCOLOGY RESEARCH AND TREATMENT | 2023年 / 46卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

V504

引用

页码：73 / 74

页数：2

共 50 条

[21] Late Effects of CD19-Targeted CAR-T Cell Therapy
Cordeiro, Ana
Bezerra, Evandro D.
Hill, Joshua Aiden
Turtle, Cameron J.
Maloney, David G.
Bar, Merav
BLOOD, 2018, 132
[22] CD19-Targeting CAR-T Cell Therapy in CNS Lymphoma
Siddiqi, Tanya
Wang, Xiuli
Palmer, Joycelynne
Popplewell, Leslie L.
Nikolaenko, Liana
Herrera, Alex F.
Budde, Lihua E.
Lim, Laura
Vyas, Vibhuti
Brown, Christine E.
Forman, Stephen J.
BLOOD, 2019, 134
[23] THE DARK SIDE OF CORTICOSTEROIDS IN CD19. CAR-T CELL THERAPY
Roberto, Marcello
Iannotta, Francesco
De Felice, Francesco
Casadei, Beatrice
Storci, Gianluca
De Matteis, Serena
Laprovitera, Noemi
Vaglio, Francesca
Sinigaglia, Barbara
Tomassini, Enrica
Maffini, Enrico
Arpinati, Mario
Barbato, Francesco
Ursi, Margherita
Bertuccio, Salvatore Nicola
Messelodi, Daria
Salamon, Irene
Naddeo, Maria
Dan, Elisa
Zazzeroni, Luca
Pellegrini, Cinzia
Carella, Matteo
Gentilini, Marianna
Zinzani, Pier Luigi
Bonafe, Massimiliano
Bonifazi, Francesca
BONE MARROW TRANSPLANTATION, 2024, 59 : 214 - 215
[24] Enhancing CAR-T cell functionality in a patient-specific manner
Zhang, David K. Y.
Adu-Berchie, Kwasi
Iyer, Siddharth
Liu, Yutong
Cieri, Nicoletta
Brockman, Joshua M.
Neuberg, Donna
Wu, Catherine J.
Mooney, David J.
NATURE COMMUNICATIONS, 2023, 14 (01)
[25] Enhancing CAR-T cell functionality in a patient-specific manner
David K. Y. Zhang
Kwasi Adu-Berchie
Siddharth Iyer
Yutong Liu
Nicoletta Cieri
Joshua M. Brockman
Donna Neuberg
Catherine J. Wu
David J. Mooney
Nature Communications, 14
[26] Subsequent Secondary CAR-T Cell Therapy Was Superior to Chemotherapy in Patients with Refractory/Relapsed BCell Lymphoma after Failure of Anti-CD19 CAR-T Cell Therapy
Yang, Fan
Liu, Rui
Xu, Teng
Zheng, Peihao
Feng, Shaomei
Guo, Yuelu
Ma, Lixia
Shi, Hui
Deng, Biping
Ke, Xiaoyan
Wu, Tong
Hu, Kai
BLOOD, 2022, 140 : 10384 - 10385
[27] CAR-T cell therapy for T cell malignances
Watanabe, Keisuke
CANCER SCIENCE, 2025, 116 : 1784 - 1784
[28] Secondary Malignancies after CAR-T Cell Therapy
Rudek, Loreen Sophie
Alakus, Hakan
ONKOLOGIE, 2025, 31 (01): : 110 - 111
[29] CAR-T cell therapy for T cell malignances
Watanabe, Keisuke
CANCER SCIENCE, 2024, 115 : 812 - 812
[30] Humanized CD19 CAR-T cells in relapsed/refractory B-ALL patients who relapsed after or failed murine CD19 CAR-T therapy
Lihong An
Yuehui Lin
Biping Deng
Zhichao Yin
Defeng Zhao
Zhuojun Ling
Tong Wu
Yongqiang Zhao
Alex H. Chang
Chunrong Tong
Shuangyou Liu
BMC Cancer, 22

← 1 2 3 4 5 →